Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống
1
/ 18 trang
THÔNG TIN TÀI LIỆU
Thông tin cơ bản
Định dạng
Số trang
18
Dung lượng
0,94 MB
Nội dung
Novelgloboside-likeoligosaccharideexpression patterns
in nontypeableHaemophilusinfluenzae lipopolysaccharide
Susanna L. Lundstro
¨
m
1
, Brigitte Twelkmeyer
1
, Malin K. Sagemark
1
, Jianjun Li
2
,
James C. Richards
2
, Derek W. Hood
3
, E. Richard Moxon
3
and Elke K. H. Schweda
1
1 Clinical Research Centre, Karolinska Institutet and University College of South Stockholm, Huddinge, Sweden
2 Institute for Biological Sciences, National Research Council of Canada, Ottawa, Canada
3 Molecular Infectious Diseases Group and Department of Paediatrics, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital,
Oxford, UK
Haemophilus influenzae is an important cause of
human disease worldwide and exists in encapsulated
(type a–f) and unencapsulated (nontypeable) forms.
Type b capsular strains are associated with invasive
bacteraemic diseases, including meningitis, epiglottitis,
cellulitis and pneumonia, whereas acapsular or non-
typeable strains of H. influenzae (NTHi) are primary
pathogens in otitis media and cause both acute and
chronic lower respiratory tract infections [1,2]. The
potential of H. influenzae to cause disease depends
Keywords
globoside; globotetraose; Haemophilus
influenzae; lipopolysaccharide; sialyllactose
Correspondence
E. Schweda, University College of South
Stockholm, Clinical Research Centre,
Novum, S-141 86 Huddinge, Sweden
Fax: +46 85 858 3820
Tel: +46 85 858 3823
E-mail: Elke.Schweda@crc.ki.se
(Received 29 May 2007, revised 18 July
2007, accepted 25 July 2007)
doi:10.1111/j.1742-4658.2007.06011.x
We report the novel pattern of lipopolysaccharide (LPS) expressed by two
disease-associated nontypeableHaemophilusinfluenzae strains, 1268 and
1200. The strains express the common structural motifs of H. influenzae;
globotetraose [b-d-GalpNAc-(1fi3)-a-d-Galp-(1fi4)-b-d-Galp-(1fi4)-b-d-
Glcp] and its truncated versions globoside [a-d-Galp-(1fi4)-b-d-Galp-(1fi4)-
b-d-Glcp] and lactose [b-d-Galp-(1fi4)-b-d-Glcp] linked to the terminal
heptose (HepIII) and the corresponding structures with an a-d-Glcp as the
reducing sugar linked to the middle heptose (HepII) in the same LPS mole-
cule. Previously these motifs had been found linked only to either the proxi-
mal heptose (HepI) or HepIII of the triheptosyl inner-core moiety l-a-d-
Hepp-(1fi2)-[PEtnfi6]-l-
a-d-Hepp-( 1fi3)-l-a-d-Hepp-(1fi5)-[PPEtnfi4]-
a-Kdo-(2fi6)-lipid A. This novel finding was obtained by structural studies
of LPS using NMR techniques and ESI-MS on O-deacylated LPS and core
oligosaccharide material, as well as electrospray ionization-multiple-step
tandem mass spectrometry on permethylated dephosphorylated oligosaccha-
ride material. A lpsA mutant of strain 1268 expressed LPS of reduced
complexity that facilitated unambiguous structural determination. Using
capillary electrophoresis-ESI-MS ⁄ MS we identified sialylated glycoforms
that included sialyllactose as an extension from HepII, this is a further novel
finding for H. influenzae LPS. In addition, each LPS was found to carry
phosphocholine and O-linked glycine. Nontypeable H. influenzae strain 1200
expressed identical LPS structures to 1268 with the difference that
strain 1200 LPS had acetates substituting HepIII, whereas strain 1268 LPS
has glycine at the same position.
Abbreviations
AnKdo-ol, reduced anhydro Kdo; CE, capillary electrophoresis; Hep,
L-glycero-D-manno-heptose; Hex, hexose; HexNAc, N-acetylhexosamine;
Kdo, 3-deoxy-
D-manno-oct-2-ulosonic acid; lipid A-OH, O-deacylated lipid A; LPS, lipopolysaccharide; LPS-OH, O-deacylated lipopolysaccharide;
MS
n
, multiple-step tandem mass spectrometry; Neu5Ac, N-acetyl neuraminic acid; NTHi, nontypeableHaemophilus influenzae; OS,
oligosaccharide; PCho, phosphocholine; PEtn, phosphoethanolamine; PPEtn, pyrophosphoethanolamine; tHep, terminal heptose.
4886 FEBS Journal 274 (2007) 4886–4903 ª 2007 The Authors Journal compilation ª 2007 FEBS
upon its surface-expressed carbohydrate antigens, cap-
sular polysaccharide [3] and lipopolysaccharide (LPS)
[4]. LPS is an essential and characteristic surface com-
ponent of H. influenzae. This bacterium has been
found to express short-chain LPS, lacking O-specific
polysaccharide chains and is often referred to as lipo-
oligosaccharide. Extensive structural studies of LPS
from H. influenzae by us and others have led to the
identification of a conserved glucose-substituted trihep-
tosyl inner-core moiety l-a-d-Hepp-(1fi2)-[PEtnfi6]-
l-a-d-Hepp-(1fi3)-[b-d-Glcp-(1fi4)]-l-a-d-Hepp linked
to lipid A via 3-deoxy-d-manno-oct-2-ulosonic acid
(Kdo) 4-phosphate. This inner-core unit provides the
template for attachment of oligosaccharides and non-
carbohydrate substituents [5]. The outer core region of
NTHi LPS mimics host glycolipids and the expression
of terminal epitopes is subject to high-frequency phase
variation, leading to a very heterogeneous population
of LPS molecules within a single strain. Phase varia-
tion is thought to provide an adaptive mechanism
which is advantageous for the survival of bacteria con-
fronted by the differing microenvironments and the
immune responses of the host. Several structures mim-
icking the globoside series of mammalian glycolipids
have been identified in NTHi LPS such as globotetraose
[b-d-GalpNAc-(1fi3)-a-d-Galp-(1fi4)-b-d-Galp-(1fi4)-
b-d-Glcp-(1fi], globoside [a-d
-Galp-(1fi4)-b-d-Galp-
(1fi4)-b-d-Glcp], lactose [b-d-Galp-(1fi4)-b-d-Glcp]
and sialyllactose [a-Neu5Ac-(2fi3)-b-d-Galp-(1fi4)-b-
d-Glcp(1fi] [5]. Biosynthesis of these oligosaccharide
extensions has been shown to proceed in a stepwise
fashion [6]. It has also been shown that H. influenzae
can express sialyllacto -N-neotetraose [a-Neu5Ac-(2fi3)-
b-d-Galp-(1fi4)-b-d-GlcpNAc-(1fi3)-b-d-Galp-(1fi4)-
b-d-Glcp-(1fi] or the related structure, ( PEtnfi6)-a
-d-
GalpNAc-(1fi6)-b-d-Galp-(1fi4)-b-d-GlcpNAc-(1fi3)-
b-d-Galp-(1fi4)-b-d-Glcp-(1fi, both linked to l-gly-
cero-d-manno-heptose (Hep)I. Biosynthesis of these ter-
minal tetrasaccharide moieties has been found to
resemble that of the O-antigen repeating unit, with the
tetrasaccharide being added en bloc [7]. Noncarbo-
hydrate substituents such as pyrophosphoethanolamine
(PPEtn), phosphoethanolamine (PEtn), phosphocholine
(PCho), acetate (Ac) and glycine (Gly) are common in
NTHi LPS [5].
Our previous studies have focused on the conserva-
tion and variability of patterns of LPS expressed in a
representative set of NTHi clinical isolates obtained
from otitis media patients [8–16] and relating this to the
role of LPS in commensal and virulence behaviour.
Recently, we demonstrated that oligosaccharides
containing terminal sialic acid epitopes are essential
virulence determinants in experimental otitis media [17].
In this study, we present novel LPS structures
expressed in NTHi strains 1268 and 1200. The strains
were previously shown to be very closely related [18].
Herein, we demonstrate that the two strains, as pre-
dicted, have almost identical LPS structures, the only
difference being the presence of O-acetyl groups in
strain 1200. Both strains were found to express LPS
glycoforms containing globoside and globoside-like
epitopes extending simultaneously from HepIII and
HepII, respectively. These LPS glycoforms have not
previously been found in H. influenzae. In order to
unambiguously establish this, we made use of a geneti-
cally defined isogenic mutant strain, NTHi 1268lpsA,
which had oligosaccharide extensions from HepI and
HepII only. The mutant strain also allowed us to iden-
tify sialyllactose units substituting HepII. This is the
first time that sialyllactose has been detected in that
molecular environment. The presence of sialylated gly-
coforms likely contributes to the resistance of the
strain to killing by normal human serum.
Results
NTHi wild-type strains 1268 and 1200 and mutant
strain 1268lpsA
NTHi strains 1268 and 1200 are clinical isolates origi-
nating from the Finnish Otitis Media Study Group. The
strains have the same ribotype, and by multilocus
sequence typing had identical nucleotide sequences in
three of seven LPS alleles [18]. Because of the hetero-
geneous mixtures of LPS glycoforms typical of wild-type
NTHi strains, a lpsA mutant strain of 1268 was made to
facilitate the elucidation of its structure. It has previ-
ously been shown that the lpsA gene is responsible for
addition of a hexose (Hex) to the distal heptose (HepIII)
of the inner-core of the Hi LPS molecule [6]. By disrupt-
ing the lpsA gene, we sought to construct a mutant
(1268lpsA) lacking any chain elongation from HepIII,
but otherwise identical to the wild-type 1268 strain. The
two NTHi wild-type and the 1268lpsA mutant strains
were grown in liquid media, the bacteria harvested and
desiccated, the LPS was then isolated by extraction
using the phenol ⁄ chloroform ⁄ light petroleum method.
Characterization of LPS from NTHi strains 1268,
1200 and 1268lpsA
In earlier investigations it was found that the LPS of
NTHi strains 1268 and 1200 contained ester-linked
glycine and Neu5Ac, as shown by high-performance
anion-exchange chromatography with pulsed ampero-
metric detection following treatment of samples with
S. L. Lundstro
¨
m et al. LPS structure of NTHi strains 1268 and 1200
FEBS Journal 274 (2007) 4886–4903 ª 2007 The Authors Journal compilation ª 2007 FEBS 4887
0.1 m NaOH and neuraminidase [19,20]. Furthermore,
the lipid A backbone of the respective LPS has been
described by Helander et al. [21,22].
LPS from all strains was treated with anhydrous
hydrazine under mild conditions to give the water-sol-
uble O-deacylated lipopolysaccharide (LPS-OH) which
was subjected to compositional and linkage analyses as
well as ESI-MS.
Compositional sugar analysis of LPS-OH from the
wild-type strain (1268) indicated d-glucose (Glc),
d-galactose (Gal), 2-amino-2-deoxy-d-glucose (GlcN),
2-amino-2-deoxy-d-galactose (GalN) and l-glycero-d-
manno-heptose (Hep) in a ratio of 32 : 28 : 21 : 9 : 10,
as identified by GLC-MS of their corresponding alditol
acetate and 2-butyl glycoside derivatives (Table S1).
Sugar analysis of LPS-OH from strain 1200 revealed
the presence of the same sugars as in 1268 in compara-
ble amounts (Table S1).
LPS-OH samples were dephosphorylated with 48%
hydrogen fluoride prior to methylation analysis. Mate-
rial from 1268 showed terminal Glc, terminal Gal,
4-substituted Gal, 4-substituted Glc, 3-substituted Gal,
terminal Hep, 2-substituted Hep, 3,4-substituted Hep,
terminal GalN, 2,3-substituted Hep, 4-substituted
GlcN and 6-substituted GlcN in the relative amounts
of 16 : 4 : 7 : 14 : 3 : 11 : 6 : 14 : 2 : 19 : 2 : 2. Meth-
ylation analysis on dephosphorylated LPS-OH from
NTHi strain 1200 revealed the presence of the same
sugars as 1268 in comparable amounts (Table S2). The
methylation analysis data were consistent with trian-
tennary structures in NTHi 1268 and 1200, containing
the common inner-core element, l-a-d-Hepp-(1fi2)-
l-a-d-Hepp-(1fi3)-[b-d-Glcp-(1fi4)]-l-a-d-Hepp-(1fi5)-
a-Kdop of H. influenzae LPS.
The ESI-MS spectrum of LPS-OH from 1268 revealed
abundant molecular peaks corresponding to triply and
quadruply deprotonated ions (Table 1). The MS data
indicated the presence of heterogeneous mixtures of
glycoforms, consistent with each molecular species con-
taining the conserved PEtn substituted triheptosyl
inner-core moiety attached via a phosphorylated Kdo
linked to the O-deacylated lipid A (lipid A-OH). As a
characteristic feature, populations of glycoforms were
observed that differed by 123 Da (i.e. a PEtn group),
consistent with either phosphate or PPEtn substitution
at the O-4 position of the Kdo residue [23–25]. For clar-
ity, glycoforms containing five Hex with no N-acetyl-
hexosamine (HexNAc) residue are referred to as Hex5
glycoforms. Glycoforms containing five Hex including a
HexNAc residue are referred to as HexNAcHex4 glyco-
forms. In the ESI-MS spectrum (negative mode) major
quadruply charged ions were observed at m ⁄ z 609.4 and
640.2 corresponding to glycoforms with respective com-
positions PChoÆHex
2
ÆHep
3
ÆPEtnÆPÆKdoÆlipid A-OH
and PChoÆHex
2
ÆHep
3
ÆPEtn
2
ÆPÆKdoÆlipid A-OH. Ions
corresponding to HexNAc containing glycoforms with
respective compositions PChoÆHexNAcÆHex
4
ÆHep
3
Æ
PEtnÆPÆKdoÆlipid A-OH and PChoÆHexNAcÆHex
4
ÆHep
3
Æ
PEtn
2
ÆPÆKdoÆlipid A-OH, and PChoÆHexNAcÆHex
5
Æ
Hep
3
ÆPEtnÆPÆKdoÆlipid A-OH and PChoÆHexNAcÆHex
5
Æ
Hep
3
ÆPEtn
2
ÆPÆKdoÆlipid A-OH were detected at m ⁄ z
741.3 ⁄ 772.1 and 781.8 ⁄ 812.8. Furthermore, glycoforms
with compositions PChoÆHex
5
ÆHep
3
ÆPEtnÆPÆKdoÆlipid
A-OH and PChoÆHex
5
ÆHep
3
ÆPEtn
2
ÆPÆKdoÆlipid A-OH
were indicated at m ⁄ z 731.1 and 761.7, respectively.
Peaks of low intensity corresponding to a minor Hex-
NAcHex4 glycoform without a PCho substituent were
also identified. The ESI-MS spectrum of LPS-OH from
strain 1200 showed the same ions as 1268 except for
those corresponding to HexNAcHex4 glycoforms with-
out a PCho substituent (Table 1).
ESI-MS data of LPS-OH from 1268lpsA showed less
heterogeneity with no indications of Hex5 or HexNAc-
Hex5 glycoforms. Ions corresponding to the HexNAc-
Hex4 glycoforms lacking PCho were moderately higher
in abundance in 1268lpsA than in 1268 (Table 1).
Ions corresponding to sialylated glycoforms were
not unambiguously identified in the full ESI-MS spec-
tra of LPS-OH samples due to extensive overlap with
those corresponding to major, nonsialylated glyco-
forms, and ⁄ or low abundance. However, their presence
was confirmed for LPS-OH of 1268lpsA in precursor
ion monitoring tandem mass spectrometry experiments
by scanning for loss of m ⁄ z 290 (Neu5Ac, negative ion
mode) or m ⁄ z 274 (Neu5Ac-H
2
O, positive mode) fol-
lowing capillary electrophoresis (CE)-ESI-MS ⁄ MS.
The data are shown in Fig. 1 and summarized in
Table S3. In the precursor negative-mode ion-scan
spectrum (Fig. 1A) quadruply and triply charged ions
corresponding to a complex mixture of sialylated gly-
coforms containing three to six hexose residues were
observed. The major ion at m ⁄ z 909.5 corresponded to
a Hex3 glycoform with the composition Neu5AcÆ Hex
3
Æ
Hep
3
ÆPEtnÆPÆKdoÆlipid A-OH. Particularly noteworthy
are HexNAc-containing glycoforms detected at m ⁄ z
1086.0, 1127.5, 1180.5, 1207.0 and 1249.5 having the
respective compositions, PChoÆNeu5AcÆHexNAcÆHex
4
Æ
Hep
3
ÆPEtnÆPÆKdoÆlipid A-OH, PChoÆNeu5AcÆHexNAcÆ
Hex
4
ÆHep
3
ÆPEtn
2
ÆPÆKdoÆlipid A-OH, PChoÆNeu5AcÆ
HexNAcÆHex
5
ÆHep
3
ÆPEtn
2
ÆPÆKdoÆlipid A-OH, PChoÆ
Neu5AcÆHexNAc
2
ÆHex
5
ÆHep
3
ÆPEtnÆ PÆKdoÆ lipid A-OH
and PChoÆNeu5AcÆHexNAc
2
ÆHex
5
ÆHep
3
ÆPEtn
2
ÆPÆKdoÆ
lipid A-OH. In the precursor ion scan spectrum
obtained in the positive mode (Fig. 1B) ions corre-
sponding to sialylated Hex3 glycoforms were not
observed, whereas ions corresponding to sialylated
LPS structure of NTHi strains 1268 and 1200 S. L. Lundstro
¨
m et al.
4888 FEBS Journal 274 (2007) 4886–4903 ª 2007 The Authors Journal compilation ª 2007 FEBS
glycoforms containing HexNAc were readily detected
confirming their presence.
Characterization of oligosaccharides derived from
NTHi strains 1268, 1200 and 1268lpsA
Mild acid hydrolysis of LPS with dilute aqueous acetic
acid afforded insoluble lipid A and core oligosaccharide
material (OS), which after purification by gel-filtration
chromatography resulted in OS samples from the vari-
ous strains. Strains 1268 and 1200 gave leading fractions
of higher molecular mass referred to as 1268OS
and 1200OS which were investigated in detail.
Strain 1268lpsA gave lpsAOS.
Sugar analyses (Table S1) performed on 1268OS,
lpsAOS and 1200OS were consistent with the data
obtained on LPS-OH for both the wild-type and
mutant strains, revealing the presence of Glc, Gal,
Table 1. Negative ion ESI-MS data and proposed compositions for LPS-OH and OS of strains 1268, 1200 and 1268lpsA. Average mass units
were used to calculate molecular mass based on proposed compositions as follows: Hex, 162.14; HexNAc, 203.19; Hep, 192.17; Kdo,
220.18; P, 79.98; PEtn, 123.05; PCho, 165.13; AnKdo-ol, 222.20; Gly, 57.05; Ac, 42.04; lipid A-OH, 953.02. All LPS-OH and OS glycoforms
contain Hep
3
ÆPEtnÆPÆKdoÆlipid A-OH or Hep
3
ÆPEtnÆAnKdo-ol, respectively. nr, not rationalized.
Sample
Observed ions (m ⁄ z) Molecular mass (Da) Relative Abundance (%)
Proposed composition(M-4H)
4–
(M-3H)
3–
(M-2H)
2–
Obs Calc 1268 1268lpsA 1200
LPS-OH 609.4 812.8 2441.5 2442.2 17 36 16 PChoÆHex
2
640.2 854.1 2565.1 2565.2 30 45 34 PChoÆHex
2
ÆPEtn
680.9 2727.6 2727.3 6 PChoÆHex
3
ÆPEtn
700.1 933.7 2804.3 2804.5 2 5 HexNAcÆHex
4
731.1 974.6 2927.6 2927.5 2 3 HexNAcÆHex
4
ÆPEtn
721.3 2889.2 2889.5 7 PChoÆHex
4
ÆPEtn
731.1 975.2 2928.5 2928.6 3 4 PChoÆHex
5
741.3 988.8 2969.3 2969.6 5 5 PChoÆHexNAcÆHex
4
761.7 1015.9 3050.8 3051.6 12 8 PChoÆHex
5
ÆPEtn
772.1 1029.6 3092.1 3092.7 12 6 7 PChoÆHexNAcÆHex
4
ÆPEtn
781.8 1042.7 3131.2 3131.8 6 2 PChoÆHexNAcÆHex
5
812.8 1083.9 3255.0 3254.8 11 16 PChoÆHexNAcÆHex
5
ÆPEtn
OS 540.6 1083.2 1083.9 2 Hex
621.6 1245.2 1246.0 1 Hex
2
682.7 1367.4 – 13 nr
704.3 1410.6 1411.1 4 71 1 PChoÆHex
2
725.2 1452.4 1453.1 5 PChoÆAcÆHex
2
732.9 1467.8 1468.1 7 2 1 PChoÆGlyÆHex
2
746.3 1494.6 1495.2 4 PChoÆAc
2
ÆHex
2
754.2 1510.4 1510.2 1 PChoÆGlyÆAcÆHex
2
774.6 1551.2 1552.2 1 PChoÆGlyÆAc
2
ÆHex
2
783.8 1569.6 1570.3 3 Hex
4
785.6 1573.2 1573.2 3 PChoÆHex
3
806.9 1615.8 1615.3 2 PChoÆAcÆHex
3
866.5 1735.0 1735.4 4 1 2 PChoÆHex
4
885.5 1773.0 1773.5 3 HexNAcÆHex
4
887.5 1777.0 1777.4 4 PChoÆAcÆHex
4
895.0 1792.0 1792.4 1 PChoÆGlyÆHex
4
947.6 1897.2 1897.5 12 4 PChoÆHex
5
645.2 968.1 1938.3 1938.6 22 5 8 PChoÆHexNAcÆHex
4
968.3 1938.6 1939.5 2 PChoÆAcÆHex
5
976.0 1954.0 1954.6 2 5 PChoÆGlyÆHex
5
988.9 1979.8 1980.6 9 PChoÆAcÆHexNAcÆHex
4
988.9 1979.8 1981.6 2 PChoÆAc
2
ÆHex
5
664.5 996.3 1995.6 1995.6 8 6 PChoÆGlyÆHexNAcÆHex
4
1009.6 2021.2 2022.6 4 PChoÆAc
2
ÆHexNAcÆHex
4
1017.2 2036.4 2037.7 9 PChoÆGlyÆAcÆHexNAcÆHex
4
699.3 1049.2 2100.7 2100.7 33 12 PChoÆHexNAcÆHex
5
1069.9 2141.8 2142.7 15 PChoÆAcÆHexNAcÆHex
5
718.3 1077.5 2157.5 2157.8 7 PChoÆGlyÆHexNAcÆHex
5
S. L. Lundstro
¨
m et al. LPS structure of NTHi strains 1268 and 1200
FEBS Journal 274 (2007) 4886–4903 ª 2007 The Authors Journal compilation ª 2007 FEBS 4889
Hep, GalN and GlcN. The considerable decrease in
GlcN in the OS samples confirmed this sugar to be
part of lipid A but also indicated traces of glycoforms
that contain GlcN.
1268OS, lpsAOS and 1200OS were dephosphorylated
with 48% hydrogen fluoride prior to methylation anal-
ysis. Methylation analysis (Table S2) on the resulting
material from 1268OS showed terminal Glc, terminal
Gal, 4-substituted Gal, 4-substituted Glc, 3-substituted
Gal, terminal Hep, 2-substituted Hep, 3,4-substituted
Hep, terminal GalN, 2,3-substituted Hep and 4-substi-
tuted GlcN. Methylation analysis performed on nonde-
phosphorylated 1268OS revealed the same sugars but
with a decrease in terminal Glc, 4-substituted Glc and
2,3-substituted Hep, which indicated phosphorylation
on those sugars (data not shown). Methylation analy-
sis on dephosphorylated lpsAOS gave the same sugar
derivatives as 1268OS but showing a significant
increase in terminal Hep and the absence of 2-substi-
tuted Hep. Moreover, a decrease of 4-substituted Gal,
4-substituted Glc and 3-substituted Gal was observed
in the methylation analysis of this OS sample. Methyl-
ation analysis data for 1200OS was comparable with
the data obtained for 1268OS (Table S2).
ESI-MS on OS samples (Table 1) indicated all
strains to be glycylated. In addition, OS samples from
NTHi 1200 showed ions corresponding to acetylated
glycoforms. ESI-MS on 1268OS and 1200OS revealed
major HexNAcHex4 and HexNAcHex5 glycoforms.
Lower molecular mass glycoforms were minor, in
agreement with OS samples being leading fractions
after GPC. Glycoforms, of which the O-glycylated
ones were of minor abundance, were evidenced as
doubly negatively charged ions as follows: PChoÆ
Hex
2
ÆHep
3
ÆPEtnÆAnKdo-ol and PChoÆGlyÆHex
2
ÆHep
3
Æ
PEtnÆAnKdo-ol (m ⁄ z 704.3 ⁄ 732.9), PChoÆHex
5
ÆHep
3
Æ
PEtnÆAnKdo-ol and PChoÆGlyÆHex
5
ÆHep
3
ÆPEtnÆ
AnKdo-ol (m ⁄ z 947.6 ⁄ 976.0), PChoÆHexNAcÆHex
4
Æ
Hep
3
ÆPEtnÆAnKdo-ol and PChoÆGlyÆHexNAcÆHex
4
Æ
Hep
3
ÆPEtnÆAnKdo-ol (m ⁄ z 968.1 ⁄ 996.3), and PChoÆ
HexNAcÆHex
5
ÆHep
3
ÆPEtnÆAnKdo-ol and PChoÆGlyÆ
HexNAcÆHex
5
ÆHep
3
ÆPEtnÆAnKdo-ol (m ⁄ z 1049.2 ⁄
1077.5). In addition, ions at m ⁄ z 866.5 ⁄ 895.0 indicated
the glycoforms PChoÆHex
4
ÆHep
3
ÆPEtnÆAnKdo-ol and
PChoÆGlyÆHex
4
ÆHep
3
ÆPEtnÆAnKdo-ol. The glycoforms
indicated in lpsAOS were in agreement with those
found in the equivalent LPS-OH and showed major
Hex2 glycoforms.
ESI-MS data of 1200OS revealed the presence of
glycoforms substituted by up to two acetate groups.
Information on the location of Ac was provided by ESI
multiple-step tandem mass spectrometry (MS
n
)inthe
positive-ion mode. The product ion spectrum obtained
from the molecular ion at m ⁄ z 1496.4 (composition:
PChoÆAc
2
ÆHex
2
ÆHep
3
ÆPEtnÆAnKdo-ol) (Fig. 2A) con-
tained, inter alia,theionatm ⁄ z 919.1 resulting from the
loss of Hex-HepI-AnKdo-ol. MS
3
performed on this ion
revealed a prominent ion at m ⁄ z 643.3 (composition:
PChoÆHexÆHepIIÆPEtn) (Fig. 2B) resulting from the loss
of a diacetylated heptose subunit indicative of HepIII
being substituted with two acetates. These experiments
also confirmed that PCho substituted the hexose linked
Fig. 1. CE-ESI-MS ⁄ MS spectra of LPS-OH
derived from NTHi 1268lpsA. The indicated
compositions include the PÆKdoÆlipid A-OH
element. (A) Precursor ion spectrum (nega-
tive mode) using m ⁄ z 290 as the fragment
ion for identification of sialylated compo-
nents in 1268lpsA. (B) Precursor ion spec-
trum (positive mode) using m ⁄ z 274 as the
fragment ion for identification of sialylated
components in 1268lpsA.
LPS structure of NTHi strains 1268 and 1200 S. L. Lundstro
¨
m et al.
4890 FEBS Journal 274 (2007) 4886–4903 ª 2007 The Authors Journal compilation ª 2007 FEBS
to HepII and that PEtn substituted HepII. MS
3
experi-
ments on ions corresponding to monoacetylated
glycoforms revealed the same substitution pattern (data
not shown).
Sequence analysis on dephosphorylated and
permethylated oligosaccharide samples using
ESI-MS
n
Sequence and branching details of the various glyco-
forms in 1268OS, lpsAOS and 1200OS were obtained
using ESI-MS
n
in the positive mode on dephosphoryl-
ated and permethylated material [13,26]. Because of
the increased MS response obtained by permethylation
in combination with added sodium acetate, several gly-
coforms were observed in the MS spectra that were
not detected in underivatized samples. Thus, the ESI-
MS mass spectrum of 1268OS (positive mode)
(Fig. 3A) showed sodiated singly charged adduct ions
([M+Na]
+
) corresponding to the glycoforms Hex
2
Æ
Hep
3
ÆAnKdo-ol, Hex
3
ÆHep
3
ÆAnKdo-ol, Hex
4
ÆHep
3
Æ
AnKdo-ol and Hex
5
ÆHep
3
ÆAnKdo-ol (m ⁄ z 1467.9,
1672.4, 1875.8 and 2080.1), HexNAcÆ Hex
4
ÆHep
3
Æ
AnKdo-ol and HexNAcÆHex
5
ÆHep
3
ÆAnKdo-ol (m ⁄ z
2120.8 and 2325.3) and HexNAc
2
ÆHex
4
ÆHep
3
ÆAnKdo-ol
(m ⁄ z 2366.7). The HexNAc2Hex4 glycoform was not
detected in the underivatized samples due to low
abundance.
In order to obtain sequence and branching informa-
tion, these molecular ions were further fragmented in
MS
2
and MS
3
experiments. For most glycoforms the
presence of several isomeric compounds was revealed
by identifying product ions in MS
2
spectra (Table S4).
MS
3
experiments were used when necessary to confirm
structures.
Two isomeric Hex2 glycoforms were identified in
1268OS by fragmenting the molecular ion m ⁄ z 1467.9.
The resulting spectrum revealed ions at m ⁄ z 1206.1
(major) and 1002.0 (minor) corresponding to loss of
terminal (t)Hep and tHex-Hep. The ion at m ⁄ z 754.3
corresponded to the fragment tHex-HepI-AnKdo-ol.
Thus in the major Hex2 isomer terminal hexoses
substituted both HepI and HepII. In the minor Hex2
glycoform both HepI and HepIII were substituted with
terminal hexose residues. Performing MS
2
on the
ion m ⁄ z 1672.4 and subsequent MS
3
on the resulting
Fig. 3. ESI-MS
n
analysis of permethylated
OS of strain 1268. (A) Full-scan spectrum
(positive mode) on permethylated dephos-
phorylated 1268OS. (B) Product ion
spectrum of [M+Na]
+
m ⁄ z 2120.8 corre-
sponding to the HexNAcHex4 glycoform.
Proposed key fragments are indicated in the
structure. (C) MS
3
of the ion at m ⁄ z 1859.0
from MS
2
of m ⁄ z 2120.8. Proposed key
fragments are indicated in the structure.
Fig. 2. ESI-MS
n
analysis of OS derived from NTHi strain 1200.
(A) Product ion spectrum of [M+H]
+
m ⁄ z 1496.4 corresponding to
the PChoÆAc
2
ÆHex
2
ÆHep
3
ÆPEtnÆAnKdo-ol glycoform. The proposed
fragmentation is shown beside the spectrum. (B) MS
3
on fragment
ion m ⁄ z 919.1, corresponding to the loss of Hex-HepI-AnKdo-ol.
The proposed fragmentation is shown beside the spectrum.
S. L. Lundstro
¨
m et al. LPS structure of NTHi strains 1268 and 1200
FEBS Journal 274 (2007) 4886–4903 ª 2007 The Authors Journal compilation ª 2007 FEBS 4891
product ions determined two major and two minor
Hex3 isomeric glycoforms. The ion corresponding to
the loss of tHepIII at m ⁄ z 1409.9 was further frag-
mented to give the ion at m ⁄ z 753.5 due to the loss of
a tHex-Hex-HepII unit, thus evidencing a structure
with one hexose residue substituted to HepI and a
disaccharide moiety substituting HepII. Furthermore,
in the same MS
3
spectrum a minor ion was detected at
m ⁄ z 957.3 corresponding to the loss of tHex-HepII.
This ion confirmed the structure of a glycoform in
which a disaccharide moiety substitutes HepI and one
hexose substitutes HepII. The ion at m ⁄ z 1206.0 corre-
sponded to the loss of tHex-HepIII from the molecular
ion. It was further fragmented to give the ion at m ⁄ z
753.4 which originated from the loss of a tHex-HepII
unit, thus indicating a structure with one hexose resi-
due substituting each heptose residue. Finally, a minor
structure with one hexose residue linked to HepI and
two hexoses linked to HepIII could be determined
when the product ion, m ⁄ z 1001.5, corresponding to
the loss of tHex-Hex-HepIII, was further fragmented
to give the ion at m ⁄ z 753.2 due to the loss of HepII.
Four isomeric Hex4 glycoforms were identified by per-
forming MS
2
on the parent ion at m ⁄ z 1875.8 and sub-
sequent MS
3
on the resulting product ions at m ⁄ z
1614.0, 1206.1 and 1001.7 due to the losses of a termi-
nal heptose, a terminal Hex-Hex-Hep residue and a
terminal Hex-Hex-Hex-Hep residue, respectively.
When the ion at m ⁄ z 1614.0 was further fragmented in
aMS
3
experiment it gave product ions at m⁄ z 883.5
and 753.4 due to losses of the epitopes tHex-HepI-
AnKdo-ol and tHex-Hex-Hex-HepII, respectively. Fur-
thermore, a product ion at m⁄ z 1161.2 indicated the
loss of tHex-HepII. Thus two structures with terminal
HepIII were identified: the first with one hexose linked
to HepI and a trisaccharide group linked to HepII and
the second containing elongation of a trisaccharide
group substituting HepI and one hexose on HepII.
When the ion at m ⁄ z 1206.1 was further fragmented in
MS
3
experiments a product ion at m ⁄ z 753.4 was
observed defining the loss of tHex-HepII, which indi-
cated a major glycoform containing a disaccharide unit
on HepIII and one hexose residue on each of HepI
and HepII. The product ion at m ⁄ z 1001.7 was further
fragmented to give the ion at m ⁄ z 753.3 due to the loss
of HepII, revealing a minor glycoform containing a tri-
saccharide unit on HepIII and with one hexose on
HepI. One isomeric Hex5 glycoform was observed by
fragmenting the molecular ion at m ⁄ z 2080.1. The iso-
mer was defined by the ions at m ⁄ z 1349.9 and 1206.2
corresponding to the loss of tHex-HepI-AnKdo-ol and
tHex-Hex-Hex-HepIII which indicated HepI to be
substituted by one hexose and HepIII to be elongated
by three hexoses. The structure was confirmed in MS
3
experiments on m ⁄ z 1206.2 where the product ion at
m ⁄ z 754.4 indicated the loss of tHex-HepII.
The molecular ion at m ⁄ z 2120.8 corresponded to a
glycoform with four hexoses and one hexosamine. One
single isomer (Fig. 3B,C) was identified by fragmenting
the molecular ion. In the resulting spectrum, fragment
ions were observed at m ⁄ z 1862.4, 1859.0 and 1390.7
resulting from the loss of tHexNAc, tHep and tHex-
HepI-AnKdo-ol, respectively. A MS
3
experiment on
m ⁄ z 1859.0, showing the loss of tHex-HepI-AnKdo-ol
(m ⁄ z 1129.4) confirmed that this glycoform contained
a tHexNAc-Hex-Hex-Hex elongation from HepII and
a single hexose substituting HepI. The molecular ion
at m ⁄ z 2325.3 corresponded to a HexNAcHex5 glyco-
form. When this ion was further fragmented it gave
ions at m ⁄ z 2065.5, 1594.8 and 1205.9 resulting from
the loss of tHexNAc, tHex-HepI-AnKdo-ol and tHex-
NAc-Hex-Hex-Hex-Hep, respectively. The ion at m ⁄ z
1205.9 was further fragmented to give the ion at m ⁄ z
754.1 due to the loss of a tHex-HepII unit, thus evi-
dencing a structure with one hexose residue substituted
to each of HepI and HepII, and a tetrasaccharide moi-
ety with terminal hexosamine substituting HepIII.
The molecular ion at m ⁄ z 2366.7 corresponded to
a glycoform with the composition HexNAc
2
ÆHex
4
Æ
Hep
3
ÆAnKdo-ol. The single isomer of this glycoform
was defined in the MS
2
spectrum by the ions at m ⁄ z
2108.0, 2105.0, 1903.5 and 1658.3 corresponding to the
loss of tHexNAc, tHep, tHexNAc-Hex and tHexNAc-
Hex-HexNAc. MS
3
performed on the ion at m ⁄ z
1658.3 indicated the loss of tHep (m ⁄ z 1396.1) and
the fragment ion of -Hex-Hex-HepI-AnKdo-ol (m ⁄ z
944.1). Thus, this glycoform contained a tHexNAc-
Hex-HexNAc-Hex-Hex- unit elongating from HepI
and with one hexose substituting HepII.
ESI-MS
n
data obtained from lpsAOS clearly indi-
cated the absence of glycoforms expressing chain
extension from HepIII. The major isoforms observed
were otherwise equivalent to those found in the wild-
type strain, except for an extra Hex1 glycoform (m ⁄ z
1264.1) containing one hexose substituent on HepI
determined from the fragment ion at m ⁄ z 753.2 indi-
cating the loss of tHepIII-HepII (Table S4).
Strain 1200 contained virtually the same glycoforms
as observed in strain 1268 except for those having
elongations from HepI. However, traces of three other
higher molecular mass forms; HexNAcÆHex
6
ÆHep
3
Æ
AnKdo-ol, HexNAcÆHex
7
ÆHep
3
ÆAnKdo-ol and Hex-
NAc
2
ÆHex
7
ÆHep
3
ÆAnKdo-ol at m ⁄ z 2528.9, 2732.9 and
2976.9, respectively, were observed and investigated.
MS
2
of m ⁄ z 2528.9 gave fragment ions at m ⁄ z 2269.2,
1410.0 and 1799.5 corresponding to losses of
LPS structure of NTHi strains 1268 and 1200 S. L. Lundstro
¨
m et al.
4892 FEBS Journal 274 (2007) 4886–4903 ª 2007 The Authors Journal compilation ª 2007 FEBS
tHexNAc, tHexNAc-Hex-Hex-Hex-HepIII and tHex-
HepI-AnKdo-ol, indicating HepI to be substituted by
one hexose, HepII by two hexoses and HepIII by
a tHexNAc-Hex-Hex-Hex unit. The same spectrum
showed a second glycoform defined by the ion at m ⁄ z
1859.7 indicating that HepIII was elongated with two
hexoses. This was confirmed by MS
3
on the ion at
m ⁄ z 1799.5 giving the fragment ion at m ⁄ z 1128.9
corresponding to the loss of tHex-Hex-HepIII, thus
indicating HepII to be substituted by a tHexNAc-Hex-
Hex-Hex- unit. MS
2
of m ⁄ z 2732.9 gave fragment ions
at m ⁄ z 2474.4, 1613.7 and 2002.9 corresponding to the
losses of tHexNAc, tHexNAc-Hex-Hex-Hex-HepIII
and tHex-HepI-AnKdo-ol, respectively, revealing HepI
to be substituted by one hexose, HepII by three
hexoses and HepIII by the tHexNAc-Hex-Hex-Hex
unit. MS
2
of m ⁄ z 2976.9 gave the fragment ions m ⁄ z
2718.4 and 1858.5, indicating the loss of tHexNAc and
tHexNAc-Hex-Hex-Hex-HepIII. The ion at m ⁄ z 1858.5
was further fragmented which gave the fragment ions
at m ⁄ z 1599.7 and 1129.0 corresponding to the losses
of tHexNAc and tHex-HepI-AnKdo-ol. This indicated
the HexNAc2Hex7 isomer to be substituted by one
hexose at HepI and tHexNAc-Hex-Hex-Hex units
substituting both HepII and HepIII.
Characterization of lpsAOS, 1268OS and 1200OS
by NMR
Major structures were elucidated by detailed
1
H,
13
C
and
31
P NMR analyses.
1
H and
13
C NMR resonances
were assigned using gradient chemical shift correlation
techniques (COSY, TOCSY and HMQC experiments).
The chemical shift data corresponding to 1268OS,
lpsAOS and 1200OS are given in Table 2. Prior to
NMR analyses the samples were treated with 1 m NH
3
to remove O-acyl groups. Subspectra corresponding to
the individual glycosyl residues were identified on the
basis of spin-connectivity pathways delineated in the
1
H chemical shift correlation maps, the chemical shift
values, and the vicinal coupling constants. The mono-
saccharide sequences of the major glycoforms were
confirmed from transglycosidic NOE connectivities
between anomeric and aglyconic protons on adjacent
residues (Table S5). The chemical shift data are consis-
tent with each sugar residue being present in the pyr-
anosyl ring form. Further evidence for this conclusion
was obtained from NOE data which also served to
confirm the anomeric configurations of the linkages
and the monosaccharide sequence. NOESY spectra of
1268OS, lpsAOS and 1200OS revealed inter-residue
NOE connectivities between the anomeric protons of
HepIII to HepII H-1 ⁄ H-2, HepII to HepI H-3, HepI
to Kdo H-5 ⁄ H-7 and GlcIV to HepI H-4 ⁄ H-6, which
confirmed the sequence of the conserved triheptosyl
inner core unit. Several signals for methylene protons
of An Kdo-ol were observed in the COSY and TOCSY
spectra in the region d 1.87–2.18. This is due to the
fact that several anhydro-forms of Kdo are formed
during the hydrolysis by elimination of phosphate or
pyrophosphoethanolamine from the C-4 position [27].
1
H–
31
P correlation experiments indicated PEtn
(d
P
0.01) to be linked to O-6 of HepII.
Structure of the Hex2, Hex4 and HexNAcHex4
glycoforms in lpsAOS
Sequence analysis of lpsAOS by ESI-MS
n
revealed a
predominant Hex2 glycoform having a triheptosyl
inner-core from which chain elongation by hexoses
only appeared from HepI and HepII (Table S4). In
addition, glycoforms having further extensions from
HepII by HexNAc-Hex-Hex-Hex or truncated versions
thereof were detected. In the
1
H NMR spectrum of
lpsAOS, anomeric resonances corresponding to the
triheptosyl moiety (HepI–HepIII) were identified at
d 5.05–5.16, 5.83 and 5.03, respectively. Subspectra cor-
responding to the hexose residues were identified in the
2D COSY and TOCSY (Fig. 4A) spectra at d 5.28
(Glc residue V), 4.97 (Gal residue VII), 4.92 (Gal resi-
due VII), 4.66 (GalNAc residue VIII), 4.57 ⁄ 4.64 (Gal
residue VI) and 4.54 (Glc residue IV), respectively. The
chemical shift data were consistent with VII (d
H-1
4.97)
and VIII being terminal residues. The terminal and
4-substituted forms of residue V could be distinguished
by different H-2 and H-4 shifts (d
H-2
3.54 ⁄ 3.59 and
d
H-4
3.50 ⁄ 3.80), which was also confirmed in COSY
and
1
H)
13
C HMQC experiments (d
C-4
69.8 ⁄ 76.3). The
high H-6
A ⁄ B
shifts of V (d 4.11 ⁄ 4.18) indicated this
position to be substituted with a PCho subunit, which
was confirmed in
1
H–
31
P correlation experiments
showing a
31
P resonance at d )0.05 correlating to
H-6
A ⁄ B
of V and the methylene protons of PCho at
d 4.35. The spin systems at d 4.57 and 4.64 could both
be assigned to residue VI indicating the anomeric
proton of this residue to be sensitive to changes in
molecular environment due to the microheterogeneity
of the sample. Because the oligosaccharide contains
Hex4 glycoforms with and without PCho, we assume
that the proton at d 4.57 corresponds to glycoforms
substituted by PCho and the one at d 4.64 to those
that do not. Inter-residue NOE between the proton
pairs of V H-1 ⁄ II H-3 confirmed these residues to be
linked to position O-3 in HepII. Inter-residue NOE
were observed between the VII H-1 ⁄ VI H-4 confirming
a a-d-Galp-(1fi4)-b-d-Galp unit within the extension
from HepII. Inter-residue NOE from VI H-1 and
S. L. Lundstro
¨
m et al. LPS structure of NTHi strains 1268 and 1200
FEBS Journal 274 (2007) 4886–4903 ª 2007 The Authors Journal compilation ª 2007 FEBS 4893
Table 2.
1
H and
13
C chemical shifts for 1268OS, lpsAOS and 1200OS. Prior to NMR analyses the samples were O-deacylated. Spectra were
recorded in D
2
Oat25°C. Chemical shift values compared between the three strains could vary by up to ± 0.01 p.p.m. Signals originating
from the Hex5 and HexNAcHex5 glycoforms were not observed in the lpsA mutant. Signals corresponding to PCho methyl protons and car-
bons occurred at d 3.23 and 54.7, respectively. Pairs of deoxy protons of reduced AnKdo-ol were identified in COSY and TOCSY spectra at d
1.87–2.18. Signals corresponding to GalNAc methyl
1
H and
13
C occurred at d 2.05 and 23.02, respectively.
a
Observed from intense NOE signals.
b
–, not determined.
c
Observed in TOCSY of strain 1268 only.
d
Observed as intra-residue NOE from
H-1 of d 4.64 only.
e
An extra terminal b-hexose was observed in strain 1200 and 1268 (weak) at d
H-1,C-1
4.46, 102.7; d
H-2,C-2
3.54,72.9;
d
H-3,C-3
3.69,72.7; d
H-4
3.54 and d
H-5
3.74, respectively. Also, intra-residue NOE signals from the anomeric proton to H-3 and H-5 were
observed. No inter-residue NOE connections could be detected.
LPS structure of NTHi strains 1268 and 1200 S. L. Lundstro
¨
m et al.
4894 FEBS Journal 274 (2007) 4886–4903 ª 2007 The Authors Journal compilation ª 2007 FEBS
V H-3 were not observed, probably due to low abun-
dance of the corresponding glycoforms. However,
NMR data combined with data from methylation and
tandem MS analysis corroborate the sequence of the
extending glycose unit from HepII as [b-d-GalNAcp-
(1fi3)-a-d-Galp-(1fi4)-b-d-Galp-(1fi4)-a-d-Glcp-(1fi].
The HexNAcHex4 glycoform in lpsAOS is shown in
Fig. 5. Also indicated are the truncated Hex4 and
Hex2 glycoforms.
Structure of the Hex5 and HexNAcHex5 glycoforms in
1268OS and 1200OS
Sequence analysis of 1268OS by ESI-MS
n
revealed in
addition to HexNAcHex4 glycoforms, abundant Hex-
NAcHex5 glycoforms having the structure observed
for lpsAOS and also those with chain elongation from
HepIII (Table S4). In the
1
H NMR spectrum of
1268OS (Fig. S1A), anomeric resonances correspond-
ing to the triheptosyl moiety (HepI–HepIII) were iden-
tified at d 5.05–5.16, 5.71 and 5.13, respectively. Spin
systems corresponding to the hexose residues were
identified in the COSY and TOCSY spectra. The
occurrence of inter-residue NOESY connectivities
between protons on contiguous residues in 1268OS
confirmed an identical structural element as shown in
Fig. 5. In addition, in the COSY and TOCSY spectra
of 1268OS anomeric signals at d 4.43 and 4.52 could
be attributed to fi4)-b-d-Glcp (IX) and fi4)-b-d-Galp
(X) residues, respectively. Additional spin systems cor-
responding to terminal GalNAc and Gal residues indi-
cated by methylation analysis were not observed. It
was reasonable to assume that these overlapped with
the resonances of the corresponding sugars extending
from HepII. Thus resonances at d 4.92 and 4.66 were
assigned to correspond to residues XI and XII, respec-
tively. Inter-residue NOE between X H-1 ⁄ IX H-4
and IX H-1 ⁄ III H-1,2 (Fig. 6A) gave evidence for the
fi4)-b-d-Gal p-(1fi4)-b-d-Glcp-(1fi2)-l-a-d-HepIIIp-(1fi
unit. Because inter-residue NOE between XII H-1 ⁄
XI H-3 and XI H-1 ⁄ X H-4 was observed we propose
that a globotetraose unit is the full extension from
HepIII in 1268OS. The HexNAcHex5 glycoform in
1268OS and 1200OS is shown in Fig. 7 as well as the
truncated Hex5 glycoform.
Fig. 4. Selected region of phase sensitive TOCSY spectra (mixing
time 180 ms) of (A) lpsAOS and (B) 1200OS. Cross-peaks of impor-
tance are labelled. See Table 2 for an explanation of the roman
numerals. (A) Signals corresponding to structures with full exten-
sion from HepII (Fig. 5) are indicated. (B) Signals corresponding to
structures with full extension from HepIII (Fig. 7) are indicated.
IV
β-
D-Glcp-(1→4)-
L
-α-D
-HepIp-(1→5)-AnKdo-ol
PCho 3
Hex4 Hex2 ↓↑
6 1
β-
D
-GalNAc
p-(1→3)-
α
-
D-Galp-(1→4)-β-
D
-Galp
-(1
→
4
)-
α
-
D
-Glc
p-(1→3)-
L
-α
-
D
-HepII
p
6←
PEtn
2
VIII VII VI V ↑
1
L
-α-D-HepIIIp
Fig. 5. Structure proposed for the HexNAcHex4 glycoform in lpsAOS. Also indicated are the truncated Hex4 and Hex2 glycoforms.
S. L. Lundstro
¨
m et al. LPS structure of NTHi strains 1268 and 1200
FEBS Journal 274 (2007) 4886–4903 ª 2007 The Authors Journal compilation ª 2007 FEBS 4895
[...]... strains has been shown to be associated with increased virulence in an in vivo model of H in uenzae infection [33] PCho substitution is a common feature of H in uenzae LPS that contributes to the ability of NTHi to colonize and persist within the human respiratory tract, at least in part by mediating bacterial adherence to and invasion of the host epithelia [34–36] A majority of H in uenzae strains, including... (1987) Nontypable Haemophilusin uenzae: a review of clinical aspects, surface antigens, and the human immune response to infection Rev Infect Dis 9, 1–15 3 Anderson P, Johnston RB Jr & Smith DH (1972) Human serum activities against Haemophilusin uenzae, type b J Clin Invest 51, 31–38 4 Zwahlen A, Rubin LG & Moxon ER (1986) Contribution of lipopolysaccharide to pathogenicity of Haemophilusin uenzae: comparative... Structural diversity inlipopolysaccharideexpressioninnontypeableHaemophilusin uenzae Identification of L-glycero-D-manno-heptose in the outer-core region in three clinical isolates Eur J Biochem 270, 610– 624 Schweda EK, Li J, Moxon ER & Richards JC (2002) Structural analysis of lipopolysaccharideoligosaccharide epitopes expressed by non-typeable Haemophilusin uenzae strain 176 Carbohydr Res... Glycine is a common substituent of the inner core inHaemophilusin uenzae lipopolysaccharide Glycobiology 11, 1009–1015 Helander IM, Lindner B, Brade H, Altmann K, Lindberg AA, Rietschel ET & Zahringer U (1988) Chemical ¨ structure of the lipopolysaccharide of Haemophilusin uenzae strain I-69 Rd- ⁄ b+ Description of a novel deeprough chemotype Eur J Biochem 177, 483–492 Mikhail I, Yildirim HH, Lindahl... Digalactoside expressionin the lipopolysaccharide of Haemophilusin uenzae and its role in intravascular survival Infect Immun 73, 7022–7026 34 Weiser JN, Pan N, McGowan KL, Musher D, Martin A & Richards J (1998) Phosphorylcholine on the lipopolysaccharide of Haemophilusin uenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein J Exp Med 187,... Structural profiling of lipopolysaccharide glycoforms expressed by non-typeable Haemophilusin uenzae: phenotypic similarities between NTHi strain 162 and the genome strain Rd Carbohydr Res 338, 2731–2744 Yildirim HH, Li J, Richards JC, Hood DW, Moxon ER & Schweda EK (2005) An alternate pattern for globoside oligosaccharideexpressioninHaemophilusin uenzae lipopolysaccharide: structural diversity in nontypeable. .. Schweda EK (2001) A new structural type for Haemophilusin uenzae lipopolysaccharide Structural analysis of the lipopolysaccharide from nontypeableHaemophilusin uenzae strain 486 Eur J Biochem 268, 2148–2159 ˚ Mansson M, Hood DW, Li J, Richards JC, Moxon ER & Schweda EK (2002) Structural analysis of the lipopolysaccharide from nontypeableHaemophilusin uenzae strain 1003 Eur J Biochem 269, 808–818 ˚ Mansson... addition of glucose or galactose to the terminal inner core heptose of Haemophilusin uenzae lipopolysaccharide via alternative linkages J Biol Chem 281, 29455–29467 30 Masoud H, Martin A, Thibault P, Moxon ER & Richards JC (2003) Structure of extended lipopolysaccharide glycoforms containing two globotriose units inHaemophilusin uenzae serotype b strain RM7004 Biochemistry 42, 4463–4475 31 Cox AD,... thus strains 1200 and 1268 are representative of this LPS structural motif in H in uenzae One glycoform containing full extension from both HepII and HepIII was identified in minor amounts in strain 1200 during permethylation analysis The proposed structure of this form is seen in Fig 8 From the structural detail obtained we can make some observations on the inclusion of epitopes in the LPS of strains 1200... Haemophilusin uenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor Mol Microbiol 37, 13–27 36 Lysenko E, Richards JC, Cox AD, Stewart A, Martin A, Kapoor M & Weiser JN (2000) The position of phosphorylcholine on the lipopolysaccharide of Haemophilusin uenzae affects binding and sensitivity to C-reactive protein-mediated killing . strains, including NTHi strains and
strain Rd, have been shown to carry PCho at O-6 of
GlcI [13,23], in other strains, including H. in uenzae
type b strains,. Novel globoside-like oligosaccharide expression patterns
in nontypeable Haemophilus in uenzae lipopolysaccharide
Susanna L.